Deep Track Capital, LP Ascendis Pharma A/S Transaction History

Deep Track Capital, LP

  • $2.27 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$99.42 - $131.97 $9.94 Million - $13.2 Million
-100,000 Reduced 12.5%
700,000 $85.5 Million
Q3 2022

Nov 14, 2022
BUY
$84.03 - $110.23 $67.2 Million - $88.2 Million
800,000 New
800,000 $82.6 Million
Q1 2022

May 16, 2022
SELL
$102.18 - $135.75 $8.17 Million - $10.9 Million
-80,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$127.1 - $169.66 $10.2 Million - $13.6 Million
80,000 New
80,000 $10.8 Million

Others Institutions Holding ASND

# of Institutions
236
Shares Held
60.2M
Call Options Held
80.3K
Put Options Held
216K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $8.66B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email